BioCube, Inc.
OOTC:BICB0.00
USD
+0.00
(-99.00%)
ISIN
US09056U1079
CUSIP
09056U107
Return %
Stock
S&P 500
1Y
-99.50
14.20
3Y
-99.96
81.12
5Y
-100.00
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Paul Lisak
- Full Time Employees
- 18
- Sector
- Electronic technology
- Industry
- Aerospace & defense
- Address
- 1531 Smithtown Avenue West Valley City NY United States 11716
- IPO Date
- Jul 24, 2007
- Website
- biocubeinc.com
- Similar Companies
- Business
- BioCube, Inc. (BICB) is a development-stage company focused on the development and marketing of lithium ion batteries in North America; the company previously engaged in marketing devices for tetrahydrocannabinol and marijuana detection, industrial and environmental monitoring, and homeland security solutions. Headquartered at 1531 Smithtown Avenue in Bohemia, New York, BioCube, Inc. operates primarily in the electrical components and equipment industry within the capital goods sector, targeting North American markets with its battery technologies. Founded prior to its public listing in August 2009 and formerly known as Alliance Network Communications Holdings, Inc., the company changed its name to BioCube, Inc. in December 2010, with Paul Lisak serving as chairman, chief executive officer, and chief financial officer. In a significant recent development effective June 28, 2025, BioCube, Inc. underwent a change in control involving a merger with BioCube Inc., a California corporation, and related agreements for the transfer of entities including A-Bold Trading, alongside the acquisition of substantial preferred stock positions through PatientTrac Limited, marking a strategic reorganization and expansion under new control group leadership.